C-peptidein type 1diabetes Maturity-Onset Diabetes of the Young (MODY) is a group of rare, inherited forms of diabetes caused by a single gene mutation, distinct from the more common type 1 and type 2 diabetes. A key diagnostic tool in identifying MODY is the c-peptide test, which measures the body's natural insulin productionGuidelines for Genetic Testing in MODY. Understanding c-peptide levels in MODY is crucial for accurate diagnosis and appropriate management, especially when differentiating it from other diabetes types like type 1 diabetes.
C-peptide is a byproduct of insulin productionGenetic testing for monogenicdiabetes(R141 and R143) will only be performed on patients confirmed to havediabetesby laboratory blood glucose or HbA1c.. When the pancreas releases insulin, it also releases an equal amount of C-peptide. Therefore, measuring c-peptide levels in the blood or urine provides an indirect assessment of how much insulin the pancreas is producing.
In MODY, while the underlying cause is genetic, many individuals retain some level of endogenous insulin production, meaning their pancreas still makes insulin. This is a critical distinction from type 1 diabetes, where the immune system destroys the insulin-producing beta cells in the pancreas, leading to little to no insulin production.
The level of fasting C-peptide measured at the time of diabetes manifestation can be particularly insightfulUpdate on clinical screening of maturity-onset diabetes of the .... In MODY, c-peptide levels can vary depending on the specific gene mutation, but they often remain detectable, indicating residual insulin secretion.Biomarkers: Tools for Discriminating MODY from Other... In contrast, individuals with type 1 diabetes typically have very low or undetectable c-peptide levels作者：R Aarthy·2023·被引用次数：15—WhenMODYwas compared to T1D (Table 2), theC-peptide(fasting and stimulated) levels showed the best sensitivity and specificity compared to .... This difference makes the c-peptide test a valuable marker for distinguishing MODY patients from autoimmune T1 diabetes.
The ability of the c-peptide test to differentiate MODY from other forms of diabetes is a significant aspect of its utility.
* MODY vs作者：P Johnston—C-peptidelevel is a measure of how much insulin an individual is producing themselves (DiabetesGenes, 2025). A low level is more suggestive of .... Type 1 Diabetes: As mentioned, a key difference lies in insulin production. While some MODY subtypes might present with very low c-peptide levels, often resembling type 1 diabetes, many will show higher or more stable levels than those seen in classic type 1 diabetes. This is why a blood or urine tested for C-peptide is a vital part of the diagnostic workup.Prevalence, Characteristics and Clinical Diagnosis of Maturity ... A fasting c-peptide level below 0作者：A Juszczak·2016·被引用次数：39—C-peptideis a helpful test in those on insulin, as it indicates endogenous insulin secretion that becomes negative in T1DM after the honeymoon ....60 ng/mL (0.20 nmol/L) is often associated with insulin deficiency characteristic of type 1 diabetes, whereas a detectable level in a younger individual with no signs of autoimmune destruction might raise suspicion for MODY作者：P Johnston—C-peptidelevel is a measure of how much insulin an individual is producing themselves (DiabetesGenes, 2025). A low level is more suggestive of ....
* MODY vs. Type 2 Diabetes: MODY is fundamentally different from type 2 diabetes, which is characterized by insulin resistance and often a gradual decline in insulin secretion over time. While both can involve detectable c-peptide levels, MODY is monogenic and often presents at a younger age with a strong family history.Maturity Onset Diabetes in the Young - StatPearls - NCBI - NIH Some studies indicate that MODY-positive individuals may have lower fasting c-peptide (FCP) levels compared to those without MODY, but this needs to be interpreted within the broader clinical context.
* Urinary C-Peptide Creatinine Ratio (UCPCR): Beyond blood tests, the urinary C-peptide creatinine ratio has emerged as a practical and non-invasive tool for discriminating between different types of diabetes, including MODY and type 1 diabetes. This ratio can offer insights into long-term insulin production and has been studied as a screening tool for specific MODY subtypes.
Several factors can influence c-peptide levels in individuals with MODY:
* Specific Gene Mutation: Different MODY subtypes (e.g., HNF1A, HNF4A, GCK) are caused by mutations in different genes, each affecting pancreatic beta-cell function and insulin secretion in unique ways. This genetic variability directly impacts c-peptide levels.
* Duration of Diabetes: As with other forms of diabetes, the duration of MODY can influence c-peptide levels. Over time, even in MODY, beta-cell function may decline, leading to lower c-peptide readings.
* Age at Diagnosis: MODY typically presents in adolescence or early adulthood, and c-peptide levels can reflect the beta-cell function at that stageC-Peptide Test: MedlinePlus Medical Test.
* Treatment: While MODY is genetic, some subtypes may initially be managed without insulin. However, as the disease progresses or depending on the subtype, insulin therapy might be initiated. For individuals on insulin, c-peptide levels are crucial to assess their remaining endogenous insulin secretion, especially during the "honeymoon period" in certain types of diabetes.
Diagnosing MODY often involves a multi-faceted approach:
1. Clinical Suspicion: Identifying individuals with a strong family history of diabetes, early age of onset (<25 years), and no signs of autoimmune markers (like autoantibodies found in type 1 diabetes) can raise suspicion for MODY.Guidelines for Genetic Testing in MODY
2. Biochemical Testing: C-peptide testing (fasting and sometimes post-prandial or stimulated) and screening for pancreatic autoantibodies are essential initial steps. The level of fasting C-peptide measured at the time of diabetes manifestation is a critical piece of data.
3. Genetic Testing: While c-peptide and autoantibody tests can strongly suggest MODY, genetic testing remains the gold standard for diagnosisUtility of Fasting C-Peptide for the Diagnostic Differentiation .... It can definitively identify the specific gene mutation responsible for the condition, allowing for precise classification and tailored management.
4.Biochemistry, C Peptide - StatPearls - NCBI Bookshelf - NIH MODY Probability Calculators: Tools that assess the likelihood of MODY based on clinical and biochemical parameters can assist clinicians in deciding when to proceed with genetic testing.
The c-peptide test is an indispensable tool in the diagnostic armamentarium for Maturity-Onset Diabetes of the Young.Utility of Fasting C-Peptide for the Diagnostic Differentiation ... By providing a measure of endogenous insulin production, it plays a vital role in differentiating MODY from type 1 diabetes and other forms of diabetes. While genetic testing offers definitive diagnosis, c-peptide measurements, along with clinical assessment and potentially urinary c-peptide creatinine ratio, provide crucial biochemical insights that guide clinicians toward identifying this often "hidden" form of diabetes, enabling more accurate diagnosis and appropriate patient care.作者：P Firdous·2022·被引用次数：8—The C-peptide is a useful marker for distinguishing MODY patients from autoimmune T1 diabetes.[57] In autoimmune T1 diabetes, residual insulin secretion ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.